<DOC>
	<DOCNO>NCT02800928</DOCNO>
	<brief_summary>A Randomized , Double-Blind , Placebo-Controlled , Crossover Design Study CERC-501 Human Laboratory Model Stress-precipitated Smoking Behavior .</brief_summary>
	<brief_title>Does CERC-501 Attenuate Stress-precipitated Smoking Lapse ?</brief_title>
	<detailed_description>The study perform subject heavy cigarette smoker currently seek treatment tobacco use disorder . The study crossover design study ( within-subject analysis ) , allow subject control . Each period crossover consist 7-day out-patient treatment period follow single out-patient testing day Day 8 . Subjects participate laboratory session follow McKee Stress-Smoking Lapse Test . Upon completion , subject undergo 7 day washout period follow second period crossover design 7-day follow-up visit .</detailed_description>
	<criteria>Inclusion Criteria 1 . Provides write informed consent agree complete require clinic visit 2 . Male female 21 60 year age inclusive 3 . Body mass index ( BMI ) 18.5 40 kg/m2 inclusive 4 . Smokes least 15 cigarette per day average past 6 month 5 . Fagerstrom score ≥5 screen 6 . Currently seek smoke cessation therapy 7 . Urine dip test cotinine concentration &gt; 150 ng/mL 8 . In otherwise good general health without unstable medical condition ( determine medical history , medication history , physical examination , 10 12 lead ECG , vital sign , clinical laboratory test ) 9 . Able read , write , speak English 10 . Females must either : 1 . Postmenopausal ( amenorrhea least 12 consecutive month ) , surgically sterile 2 . Women childbearing potential ( WOCBP ) must meet criterion : . Uses acceptable doublebarrier method contraception determine Investigator ii . Is lactate , negative serum beta human chorionic gonadotropin pregnancy test screen negative urine pregnancy test prior dose Days 1 8 treatment period . 11 . Male subject must agree use condom partner childbearing potential Exclusion Criteria 1 . Have use tobacco nicotine containing product cigarette ( e.g. , nicotine patch , pipe , cigar , snuff , chew tobacco ecigarettes ) within past 30 day 2 . Any substance use disorder nicotine caffeine assess Structured Clinical InterviewIV Axis I Disorders ( SCID ) Diagnostic Statistical Manual Mental Disorders ( DSM ) 3 . Current neurologic condition interfere study conduct , assessment treatment significant fashion 4 . Any lifetime history bipolar I , II ; schizophrenia psychotic disorder ; personality disorder , impulse control disorder assess SCIDIV 5 . Current psychiatric condition interfere study conduct , assessment , treatment significant fashion , major depressive disorder ( MDD ) , eat disorder , posttraumatic stress disorder , etc . We screen worsen symptom depression and/or suicidality medication appointment lab session participant complete Beck Depression Inventory ( BDI ) ColumbiaSuicide Severity Rating Scale ( CSSRS ) . If worsen symptom depression and/or suicidality , participant speak licensed psychologist evaluation . 6 . Recent active past history gastric disease peptic ulcer disease , gastritis , upper gastrointestinal bleeding , gastrointestinal malignancy precancerous condition 7 . Active , comorbid disease might limit ability subject participate study determine Study MD ( i.e. , poorly control diabetes mellitus , congestive heart failure , etc . ) 8 . Clinically significant clinical laboratory test take screen 9 . Elevated aspartate aminotransferase ( AST ) alanine aminotransferase ( ALT ) ≥2 time upper limit normal ( ULN ) 10 . Human immunodeficiency virus ( HIV ) , Hepatitis B Hepatitis C positive determine serology test Screening 11 . Positive ethanol breath test screen prior dosing Days 1 8 treatment period 12 . Positive urine drug test screening and/or prior dose Days 1 8 treatment period except cannabis 13 . History severe allergy multiple adverse drug reaction 14 . Known hypersensitivity CERC501 15 . Current use proton pump inhibitor histamine 2 blocker 16 . Use investigational medication within 2 month prior start study schedule receive investigational drug study drug course study 17 . Current use psychoactive medication include : antipsychotic , benzodiazepine , mood stabilizer , selective serotonin reuptake inhibitor/serotonin norepinephrine reuptake inhibitor ( SSRI/SNRI ) antidepressant mood stabilizer</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>